Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: Q4QG28
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 167 | 171 | PF00656 | 0.656 |
CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.479 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.477 |
CLV_PCSK_PC1ET2_1 | 135 | 137 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.318 |
DEG_APCC_DBOX_1 | 55 | 63 | PF00400 | 0.527 |
DEG_APCC_DBOX_1 | 8 | 16 | PF00400 | 0.590 |
DOC_CYCLIN_yCln2_LP_2 | 30 | 33 | PF00134 | 0.593 |
DOC_MAPK_MEF2A_6 | 98 | 107 | PF00069 | 0.346 |
DOC_MAPK_RevD_3 | 112 | 127 | PF00069 | 0.260 |
DOC_PP2B_LxvP_1 | 29 | 32 | PF13499 | 0.687 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.660 |
DOC_USP7_UBL2_3 | 133 | 137 | PF12436 | 0.675 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.633 |
LIG_deltaCOP1_diTrp_1 | 91 | 99 | PF00928 | 0.458 |
LIG_EH1_1 | 111 | 119 | PF00400 | 0.332 |
LIG_LIR_Gen_1 | 170 | 180 | PF02991 | 0.659 |
LIG_LIR_Nem_3 | 170 | 176 | PF02991 | 0.678 |
LIG_PDZ_Class_3 | 187 | 192 | PF00595 | 0.701 |
LIG_Pex14_1 | 93 | 97 | PF04695 | 0.458 |
LIG_SH2_CRK | 65 | 69 | PF00017 | 0.356 |
LIG_SH2_STAT3 | 57 | 60 | PF00017 | 0.619 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.375 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.663 |
LIG_SUMO_SIM_anti_2 | 26 | 32 | PF11976 | 0.667 |
LIG_SUMO_SIM_anti_2 | 47 | 53 | PF11976 | 0.636 |
LIG_SUMO_SIM_par_1 | 102 | 108 | PF11976 | 0.397 |
LIG_SUMO_SIM_par_1 | 44 | 49 | PF11976 | 0.578 |
LIG_TRAF2_1 | 164 | 167 | PF00917 | 0.696 |
LIG_WRC_WIRS_1 | 173 | 178 | PF05994 | 0.657 |
LIG_WW_3 | 31 | 35 | PF00397 | 0.594 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.748 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.762 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.792 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.700 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.500 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.713 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.634 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.495 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.426 |
MOD_PIKK_1 | 127 | 133 | PF00454 | 0.583 |
MOD_PKA_1 | 127 | 133 | PF00069 | 0.618 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.631 |
MOD_Plk_1 | 169 | 175 | PF00069 | 0.727 |
MOD_Plk_1 | 46 | 52 | PF00069 | 0.637 |
MOD_Plk_1 | 89 | 95 | PF00069 | 0.424 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.637 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.260 |
TRG_ENDOCYTIC_2 | 173 | 176 | PF00928 | 0.661 |
TRG_ER_diArg_1 | 126 | 128 | PF00400 | 0.570 |
TRG_NLS_MonoExtN_4 | 133 | 139 | PF00514 | 0.694 |
TRG_Pf-PMV_PEXEL_1 | 76 | 81 | PF00026 | 0.686 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8II27 | Leishmania donovani | 83% | 100% |
A4H7A9 | Leishmania braziliensis | 47% | 96% |
A4HVQ4 | Leishmania infantum | 83% | 100% |
E9APF0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 98% |